AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
SGLT2 Inhibitor Cardiovascular Outcome Trials - What's the Secret?
Brendan Nune is a nephrologist from Sydney, Australia. He was first involved in the Canvas program, the cardiovascular outcome trial of Canigal Flowsen. And that really became the kind of sole focus of his life for the next five or seven years. So how come you got involved for all our listeners who are young and keen to get into research? How did this happen? Brendan: "There's a lot of luck in life"